Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Revenue Drivers
CME logo

CME Group Nets $1.55B from OSTTRA Sale Amid 6% Nine-Month Revenue Growth

CME10-QFiling Date: 10/24/2025
CME Group Inc.
Description

What this story covers

CME Group's Q3 2025 10-Q shows $1.53B revenue (down 3% YoY) but 6% nine-month growth to $4.87B, driven by diversified volumes and higher fees. Net income up 9% YTD to $2.85B. Strong liquidity with $151.5B cash position; $1.55B OSTTRA sale boosts Q4. Stable risks, tech investments enhance strategy.

Story snapshot

CompanyCME Group Inc.
TickerCME
VariantStandard detailed
Duration14:05
Filing type10-Q
PeriodQ3 2025
IndustryFinancial Services
Accession0001156375-25-000206

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in